Marc Ullman was asked about Herbalife’s regulatory woes for a Yahoo Finance piece that talks about the multilevel marketer’s role as one of the hottest stocks on the market. To read the story, click here.

On October 24, John Queenan will speak at the Albany Law School lunch and learn discussing what it is like to work in the NYC Law Department. He will be accompanied by Stuart Smith, Director of Legal Recruitment and Development from the NYC Law Department.

John will speak about his experiences as an ACC  in

On November 16, 2018, Jeff Kaiser will join the faculty of the Practising Law Institute’s Life Sciences 2018: Navigating Legal Challenges in the Drug and Device Industries.

Jeff will participate on a panel entitled, “Enforcement Trends Impacting the Drug and Device Industries.” Topics covered will include the False Claims Act, the Anti-Kickback Statute, off-label promotion

Marc Ullman was quoted in a Natural Products Insider article, “FDA warns drug manufacturer marketing CBD products.”

According to FDA, all CBD products sold as supplements are noncompliant, said Ullman.

“But they [FDA officials] are using their discretion for now and acting only against the products making illegal drug claims,” Ullman informed. “The thing about enforcement discretion

Marc Ullman  will be a speaker at the Dietary Supplement Good Manufacturing Practices (GMP) Compliance Seminar, with a special section on applying GMP concepts to the cannabis industry. The program will take place at Hotel Indigo in Dallas, Texas in September 2018.

At the Dietary Supplement GMP Seminar, You Will:

• Receive detailed practical guidance

Robert Iseman was quoted in a follow up article from earlier this month with HealthLeaders Media, “ACA Risk Adjustment Payments Unfrozen.”

The article advised that after two and a half weeks of uncertainty for insurers the Centers for Medicare and Medicaid Services announced a final rule to resume risk-adjustment payments under the Affordable Care Act of

Marc Ullman was quoted in a NutraIngredients-USA article, “NAD ruling reaffirms that science on ingredients shouldn’t be extrapolated to cover finished formulation.”

The National Advertising Division has recommended that a sports nutrition marketer called VH Nutrition discontinue claims made on their supplement “TriDrive” in which they indicate boosts oxygen update capacity and speed recovery.

Ullman said, “you

Marc Ullman was quoted in a NutraIngredients-USA article, “NDI filings coming in at expected rate, FDA says, but questions on GRAS process remain.” The article focuses on the FDA’s belief that there will not be a significant change in how many companies are choosing to go through the process to file NDIs.

“I have been

Jeff Kaiser was interviewed for the Healthcare Risk Management Magazine article, “Coding Issues Carry Major Liability, Compliance Risks.” He discusses some of the major areas of coding risks for hospitals. He also explains the important role fraud reporting plays in a coding compliance program.

To read the article, click here.

Marc Ullman was quoted in a NutraIngredients-USA article, “FDA says Gottlieb statement does not signal CBD enforcement shift, but some questions unanswered, observers say.”

A statement by FDA Commissioner Dr. Scott Gottlieb noted that the US Food and Drug Administration has approved the first CBD drug, which was developed by English company GW Pharmaceuticals. The